Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional Accepts healthy volunteers

A Study of Granexin® Gel for the Reduction of Scar Formation in Surgical Wounds Following Bilateral Anchor Incision Breast Surgery

ClinicalTrials.gov ID: NCT04331080

Public ClinicalTrials.gov record NCT04331080. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 8:06 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b/3 Randomized, Prospective, Double Blind, Within-Subject Vehicle Controlled, Multi-Center Study to Determine the Efficacy and Safety of Granexin® Gel in Reducing Scar Formation in Surgical Wounds Following Bilateral Anchor Incision Breast Surgery

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate effectiveness of Granexin® gel in reducing scar formation in surgical incisional wounds.

Study identification

NCT ID
NCT04331080
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Xequel Bio, Inc.
Other
Enrollment
184 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 1, 2020 (Actual)
Primary completion
May 26, 2022 (Actual)
Completion
May 26, 2022 (Actual)
Last update posted
Jun 6, 2022

2020 – 2022

United States locations

U.S. sites
11
U.S. states
8
U.S. cities
11
Facility City State ZIP Site status
Private Clinic- David Kulber Los Angeles California 90048 —
Pasadena Surgeons Pasadena California 91105 —
Universal Axon Clinical Research Doral Florida 33166 —
Miami Plastic Surgery Miami Florida 33176 —
Ibrahim H. Amjad, MD, PA West Miami Florida 33144 —
Northwestern University - Feinberg School of Medicine - Division of Plastic & Reconstructive Surgery Chicago Illinois 60611 —
Iowa Plastic Surgery Davenport Iowa 52807 —
Luxurgery New York New York 10021 —
Wake Forest Baptist Hospital - Plastic and Reconstructive Surgery Winston-Salem North Carolina 27157 —
Integrated Aesthetics Spring Texas 77388 —
University of Utah Salt Lake City Utah 84132 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04331080, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 6, 2022 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04331080 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →